Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNorthern Jiangsu People's Hospital
About this trial
In this study,the researchers compared the changes in immune function-related indicators in patients with liver cirrhosis following laparoscopic partial splenectomy,to determine whether this surgical intervention can enhance postoperative immune function and thereby improve patient outcomes.
Eligibility criteria
Qualifiers
A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
Splenomegaly with secondary hypersplenism
gastroesophageal variceal bleeding
Informed consent to participate in the study
Disqualifiers
Hepatocellular carcinoma or any other malignancy,
Child-Pugh grade C
Recent peptic ulcer disease
History of Hemorrhagic stroke
Trial design
Treatments tested in this trial
- Laparoscopic Partial Splenectomy
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov